Times of India |
Indonesian fires worsen, Singapore smog sets record
Times of India Hospitals in Dumai and Bengkalis in Indonesia’s Riau province recorded increases in cases of asthma, lung, eye and skin problems, said health official Arifin Zainal. Free face masks were being distributed and authorities advised residents to stay … Dangerous Smog, Haze Smothers SingaporeAccuWeather.com |
OJB Jezreel Finds Kidney Donor, Requires N16Million For Transplant Surgery … – 360Nobs.com
OJB Jezreel Finds Kidney Donor, Requires N16Million For Transplant Surgery …360Nobs.comOJB Jezreel Finds Kidney Donor, Requires N16Million For Transplant Surgery (DONATE). OJB Jezreel Finds Kidney Donor, Requires N16Million For Transplant Surgery (DO…
Mum from Quedgeley died of heart failure – This is Gloucestershire
|
Mum from Quedgeley died of heart failure
This is Gloucestershire The 40-year-old mum, from Quedgeley, died on February 15 at her Azalea Gardens home. The healthy BMI range is 19 to 24. At the inquest into Ms Griffiths’ death, coroner David Dooley gave a verdict of death from natural causes as a result of heart failure. |
Death toll in Indian monsoon flooding nears 600 – KMPH FOX 26 | Central San … – KMPH Fox 26
IBNLiveDeath toll in Indian monsoon flooding nears 600 – KMPH FOX 26 | Central San …KMPH Fox 26Pa. girl, 10, doing well after 2nd lung transplant; case sparked organ allocation debateMore >>. Pa. girl, 10, doing well after 2nd lung transplant; …
Blood Donation: Noble Decision – TopNews Arab Emirates
TopNews Arab Emirates |
Blood Donation: Noble Decision
TopNews Arab Emirates Blood Donation: Noble Decision Blood donation is a great decision and reflects that donor is thinking of saving others’ lives. This is the reason when a person comes to the Western Province Blood Transfusion Service (WPTS) to donate blood then its … The Indian High Commission in Dhaka will organise a voluntary blood donation …Bangladesh News 24 hours Blood drive Friday, SaturdayFH Times |
US FDA deems Novartis' heart failure candidate a 'breakthrough' – PMLiVE
Economic Times |
US FDA deems Novartis’ heart failure candidate a ‘breakthrough’
PMLiVE The US Food and Drug Administration (FDA) has recognised that Novartis’ serelaxin could be an important step change in acute heart failure (AHF) therapy by granting it ‘breakthrough’ status. Anticipation has been growing about serelaxin (RLX030) in … Novartis heart failure drug gets FDA incentivesBioscience Technology FDA grants Breakthrough Therapy designation to Novartis’ serelaxin (RLX030 …FierceBiotech Novartis Heart-Failure Drug Wins ‘Breakthrough’ Status at FDABusinessweek Medical Daily –DailyFinance –TheHeart.Org all 13 news articles » |
Nelson Mandela improving, not about to die: Former South African president … – Times of India
Times of India |
Nelson Mandela improving, not about to die: Former South African president …
Times of India JOHANNESBURG: Anti-apartheid icon Nelson Mandela is improving in hospital as he fights a recurrent lung infection and is not ‘going to die tomorrow,’ former South African president Thabo Mbeki has said. The 94-year-old, who became South Africa’s first … Mandela hopefully coming home soon: GrandsonZee News |
Is coenzyme Q10 right for you? – Hamilton Spectator
|
Is coenzyme Q10 right for you?
Hamilton Spectator Congestive heart failure is a condition that’s on the rise in the United States and Canada; close to 6 million people have heart failure in the U.S., 500,000 in Canada. The Canadian Heart Failure Network predicts heart failure rates will see a … |
Fusion IP's Diurnal gets European boost for infant hydrocortisone treatment – Proactive Investors USA & Canada
Proactive Investors USA & Canada |
Fusion IP’s Diurnal gets European boost for infant hydrocortisone treatment
Proactive Investors USA & Canada Diurnal, one of Fusion IP’s (LON:FIP) portfolio of university spin-off companies, has cleared a major regulatory hurdel in Europe for Infacort, its hydrocortisone treatment for children. The European Medicines Agency (EMA) has approved a Paediatric … Beaufort Securities Breakfast Today including Fusion IPProactive Investors UK |
Fusion IP's Diurnal gets European boost for infant hydrocortisone treatment – Proactive Investors Australia
|
Fusion IP’s Diurnal gets European boost for infant hydrocortisone treatment
Proactive Investors Australia Diurnal, one of Fusion IP’s (LON:FIP) portfolio of university spin-off companies, has cleared a major regulatory hurdel in Europe for Infacort, its hydrocortisone treatment for children. The European Medicines Agency (EMA) has approved a Paediatric … |